Bio-Gate AG Stock
Bio-Gate AG Stock
Bio-Gate AG took a tumble today and lost -€0.035 (-6.540%).
Our community identified positive and negative aspects for Bio-Gate AG stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Bio-Gate AG stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Bio-Gate AG in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bio-Gate AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bio-Gate AG | -6.540% | -12.500% | -4.274% | -44.000% | -30.000% | -58.824% | -88.571% |
| Alpha Pro Tech Ltd. | 0.000% | -4.054% | -5.333% | 5.446% | 15.761% | 21.714% | -48.489% |
| Eifelhoehen-Klinik | 0.000% | -2.381% | 5.128% | 186.713% | 64.000% | 113.542% | 8.466% |
| Maternus-Kliniken AG | -0.530% | 4.046% | -4.762% | -28.571% | -3.226% | -53.368% | -77.387% |
News
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
EQS-Adhoc: Bio-Gate AG: Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
